Back to HomeBeta

ICD-10 Coding for Metastatic Lung Cancer(C34.9, C78.00)

Complete ICD-10-CM coding and documentation guide for Metastatic Lung Cancer. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Secondary Lung CancerLung Cancer with Metastasislung metastasis

Related ICD-10 Code Ranges

Complete code families applicable to Metastatic Lung Cancer

C34.0-C34.9Primary Range

Malignant neoplasm of bronchus and lung

Primary codes for lung cancer, used when the lung is the origin of the malignancy.

Secondary malignant neoplasm of lung

Used when the lung is a secondary site of metastasis from another primary cancer.

Secondary malignant neoplasm of brain

Used when metastasis from lung cancer spreads to the brain.

Secondary malignant neoplasm of bone

Used when metastasis from lung cancer spreads to the bone.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C34.9Malignant neoplasm of unspecified part of bronchus or lungUse when lung cancer is the primary site and specific lobe is not specified.
  • Histological confirmation of lung origin
  • Positive TTF-1 and Napsin A markers
C78.00Secondary malignant neoplasm of lung, unspecifiedUse when the lung is a secondary site of metastasis.
  • Evidence of primary cancer elsewhere
  • Imaging showing lung involvement

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for metastatic lung cancer

Essential facts and insights about Metastatic Lung Cancer

The ICD-10 code for metastatic lung cancer is C34.9 for primary and C78.00 for secondary lung involvement.

Primary ICD-10-CM Codes for metastatic lung cancer

Malignant neoplasm of unspecified part of bronchus or lung
Non-billable Code

Decision Criteria

clinical Criteria

  • Confirmed primary lung cancer with no specified lobe

Applicable To

  • Primary non-small cell lung cancer (NSCLC)

Excludes

Clinical Validation Requirements

  • Histological confirmation of lung origin
  • Positive TTF-1 and Napsin A markers

Code-Specific Risks

  • Misclassification as secondary lung cancer

Coding Notes

  • Ensure primary site is confirmed before using this code.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Encounter for antineoplastic radiation therapy

Z51.0
Use for documenting radiation therapy treatment.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Secondary malignant neoplasm of lung

C78.00
Use C78.00 when lung is a secondary site of metastasis.

Malignant neoplasm of unspecified part of bronchus or lung

C34.9
Use C34.9 when lung is the primary site.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Metastatic Lung Cancer to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C34.9.

Impact

Clinical: Leads to misinterpretation of cancer staging., Regulatory: Non-compliance with documentation standards., Financial: Potential for denied claims.

Mitigation Strategy

Use specific terminology for primary and secondary sites, Regular training on documentation standards

Impact

Reimbursement: Incorrect DRG assignment leading to financial discrepancies., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate clinical data representation.

Mitigation Strategy

Use C78.00 for secondary lung involvement.

Impact

Primary and secondary sites not properly sequenced.

Mitigation Strategy

Regular audits and training on coding guidelines.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Metastatic Lung Cancer, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Metastatic Lung Cancer

Use these documentation templates to ensure complete and accurate documentation for Metastatic Lung Cancer. These templates include all required elements for proper coding and billing.

Metastatic Lung Cancer with Brain Metastasis

Specialty: Oncology

Required Elements

  • Primary site
  • Metastatic sites
  • Histological confirmation
  • Treatment plan

Example Documentation

64M with biopsy-proven TTF-1+ adenocarcinoma (C34.1) status post 4 cycles carboplatin/pemetrexed. MRI brain: Three 8-12mm enhancing lesions (C79.31).

Examples: Poor vs. Good Documentation

Poor Documentation Example
Lung cancer with mets
Good Documentation Example
Stage IV TTF-1+ adenocarcinoma (C34.1) with C79.31 (brain) and C78.7 (liver), ECOG 1
Explanation
The good example specifies the primary site, histology, and metastatic sites, providing complete clinical context.

Need help with ICD-10 coding for Metastatic Lung Cancer? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more